It was found that RES may prevent barrier defects and inflammation by inhibiting neutrophil infiltration in mice with colitis, and RES has also been proven to inhibit TNF-α-induced inflammatory signaling and IL-8 production in Caco-2 human intestinal cells (Mayangsari and Suzuki, 2018a). Here, CXCL8 is linked to colitis.